MedTrace Logo

OxPALM: Oxford Study on Probiotics and Low Mood

NCT03801655 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-01-11

No results posted yet for this study

Summary

Probiotics are live bacteria which have been suggested to have beneficial effects not only on gut function but also on psychological and cognitive functioning. This study will investigate how a specific probiotic influences emotional and cognitive processing in participants with low mood.

Conditions

  • Mood
  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

Bio-Kult

4 capsules/day

OTHER

Placebo

4 capsules/day

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Phil Burnet, PhD · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-08-15
Completion
2020-08-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03801655 on ClinicalTrials.gov